Apollo Endosurgery Inc
NASDAQ:APEN
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Realty Income Corp
NYSE:O
|
Real Estate
|
|
US |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
|
US |
Walt Disney Co
NYSE:DIS
|
Media
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
Apollo Endosurgery Inc
Inventory
Apollo Endosurgery Inc
Inventory Peer Comparison
Competitive Inventory Analysis
Latest Figures & CAGR of Competitors
Company | Inventory | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Apollo Endosurgery Inc
NASDAQ:APEN
|
Inventory
$18.2m
|
CAGR 3-Years
27%
|
CAGR 5-Years
5%
|
CAGR 10-Years
N/A
|
|
Becton Dickinson and Co
NYSE:BDX
|
Inventory
$3.2B
|
CAGR 3-Years
4%
|
CAGR 5-Years
4%
|
CAGR 10-Years
8%
|
|
Boston Scientific Corp
NYSE:BSX
|
Inventory
$2.6B
|
CAGR 3-Years
22%
|
CAGR 5-Years
16%
|
CAGR 10-Years
11%
|
|
Stryker Corp
NYSE:SYK
|
Inventory
$5B
|
CAGR 3-Years
13%
|
CAGR 5-Years
10%
|
CAGR 10-Years
13%
|
|
Abbott Laboratories
NYSE:ABT
|
Inventory
$6.8B
|
CAGR 3-Years
8%
|
CAGR 5-Years
11%
|
CAGR 10-Years
9%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Inventory
$1.3B
|
CAGR 3-Years
31%
|
CAGR 5-Years
23%
|
CAGR 10-Years
21%
|
See Also
What is Apollo Endosurgery Inc's Inventory?
Inventory
18.2m
USD
Based on the financial report for Dec 31, 2022, Apollo Endosurgery Inc's Inventory amounts to 18.2m USD.
What is Apollo Endosurgery Inc's Inventory growth rate?
Inventory CAGR 5Y
5%
Over the last year, the Inventory growth was 52%. The average annual Inventory growth rates for Apollo Endosurgery Inc have been 27% over the past three years , 5% over the past five years .